“Estimating the budget impact of innovative pharmacological treatments for patients with type 2 diabetes mellitus in Italy: the case of liraglutide (GLP-1). ” (2022) Epidemiology, Biostatistics, and Public Health, 12(2). doi:10.2427/11082.